Faheem Hasnain
Chief Executive Officer at GOSSAMER BIO, INC.
Net worth: 4 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Troy Wilson | M | 55 | 10 years | |
| Christian Waage | M | 57 | 7 years | |
| Kleanthis Xanthopoulos | M | 66 |
SENTÉ Labs
SENTÉ, Inc. (California)
 SENTÉ, Inc. (California) Specialty StoresRetail Trade SENTÉ, Inc. provides skin care products. The firm's products include Daily Repair Complex, Neck Firming and Redness Control Complex creams. It offers dermal repair cream for people of various age groups and skin types for enhancing the skin tone, texture, elasticity, and overall appearance. The company serves customers through dermatologists and physicians in the United States. Sente was founded by Kleanthis G. Xanthopoulos and Marios Fotiadis in 2007 and is headquartered in Carlsbad, CA. | 17 years |
| Paul Schimmel | M | 83 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | 27 years |
| Mary Szela | F | 60 | 8 years | |
| Kimberly McCutcheon Jablonski | F | - | 21 years | |
| Russell Cox | M | 60 |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 6 years |
| Stelios Papadopoulos | M | 75 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 16 years |
| Thomas Daniel | M | 69 |
Aspen Neuroscience, Inc.
 Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA.
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | 6 years |
| Bryan Giraudo | M | 48 | 6 years | |
| Richard Aranda | M | 64 | 9 years | |
| Ryan Zeidan | M | - |
Sling Therapeutics, Inc.
 Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan. | - |
| John McLaughlin | M | 72 | 16 years | |
| Sandra Ramos-Alves | F | - | - | |
| Damien McDevitt | M | 57 |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | 3 years |
| Laurent Combredet | M | - |
SENTÉ, Inc. (California)
SENTÉ, Inc. (California) Specialty StoresRetail Trade SENTÉ, Inc. provides skin care products. The firm's products include Daily Repair Complex, Neck Firming and Redness Control Complex creams. It offers dermal repair cream for people of various age groups and skin types for enhancing the skin tone, texture, elasticity, and overall appearance. The company serves customers through dermatologists and physicians in the United States. Sente was founded by Kleanthis G. Xanthopoulos and Marios Fotiadis in 2007 and is headquartered in Carlsbad, CA. | 8 years |
| Andrew Spaventa | M | 39 |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | 6 years |
| James Ford | M | - | 29 years | |
| Diane Parks | F | 71 | 5 years | |
| Helen Collins | M | 62 | 3 years | |
| Teresa Bair | F | 53 | 3 years | |
| Thomas Doyle | M | 53 | 3 years | |
| Andres Bratt-Leal | M | - |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | - |
| Renée Galá | F | 52 | 6 years | |
| Gary D. Hammer | M | - |
Sling Therapeutics, Inc.
Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan. | - |
| Sandra Milligan | M | 50 | 3 years | |
| Carol Schafer | F | 60 | 3 years | |
| Marios Fotiadis | M | 51 |
SENTÉ, Inc. (California)
SENTÉ, Inc. (California) Specialty StoresRetail Trade SENTÉ, Inc. provides skin care products. The firm's products include Daily Repair Complex, Neck Firming and Redness Control Complex creams. It offers dermal repair cream for people of various age groups and skin types for enhancing the skin tone, texture, elasticity, and overall appearance. The company serves customers through dermatologists and physicians in the United States. Sente was founded by Kleanthis G. Xanthopoulos and Marios Fotiadis in 2007 and is headquartered in Carlsbad, CA. | 17 years |
| Lynn Schenk | F | 79 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | - |
| Donald R. Shepherd | M | 87 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | - |
| Thomas Malley | M | 55 | 9 years | |
| Michael A. Marletta | M | - |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | - |
| Douglas A. Bingham | M | - |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | - |
| Donna J. Weston | F | - |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | - |
| Caryn Peterson | F | 65 |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | 6 years |
| Pete de Spain | M | - | 7 years | |
| Jeffery Kelly | M | 63 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | 24 years |
| Zubin Meshginpoosh | M | - |
SENTÉ, Inc. (California)
SENTÉ, Inc. (California) Specialty StoresRetail Trade SENTÉ, Inc. provides skin care products. The firm's products include Daily Repair Complex, Neck Firming and Redness Control Complex creams. It offers dermal repair cream for people of various age groups and skin types for enhancing the skin tone, texture, elasticity, and overall appearance. The company serves customers through dermatologists and physicians in the United States. Sente was founded by Kleanthis G. Xanthopoulos and Marios Fotiadis in 2007 and is headquartered in Carlsbad, CA. | 2 years |
| John Quisel | M | 53 | 1 years | |
| Jeff Boerneke | M | - | 3 years | |
| Carolyn Ng | M | 40 |
Vertex Ventures HC
 Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | - |
| Karen Bernstein | M | 71 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | 6 years |
| Sophia Park | F | - | - | |
| Aaron Hasnain | M | - |
SENTÉ, Inc. (California)
SENTÉ, Inc. (California) Specialty StoresRetail Trade SENTÉ, Inc. provides skin care products. The firm's products include Daily Repair Complex, Neck Firming and Redness Control Complex creams. It offers dermal repair cream for people of various age groups and skin types for enhancing the skin tone, texture, elasticity, and overall appearance. The company serves customers through dermatologists and physicians in the United States. Sente was founded by Kleanthis G. Xanthopoulos and Marios Fotiadis in 2007 and is headquartered in Carlsbad, CA. | - |
| Richard van Duyne | M | - | 10 years | |
| Jonathan Lim | M | 52 |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Heyman | M | 66 |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA.
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | 6 years |
| William Rastetter | M | 76 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 26 years |
| Harry E. Gruber | M | 72 | 13 years | |
| David Parkinson | M | 73 |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | 12 years |
| Sheila Gujrathi | M | 53 | 9 years | |
| Kristina Burow | F | 50 | 13 years | |
| Richard Pascoe | M | 60 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 5 years |
| Dennis Berman | M | 73 | 10 years | |
| Robert Peach | M | 68 | 9 years | |
| Erle T. Mast | M | 61 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 7 years |
| Charles Baum | M | 65 | 12 years | |
| Francis Sarena | M | 53 |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | 4 years |
| James Basta | M | 58 | - | |
| Marc Grasso | M | 51 | 4 years | |
| Terence E. Winters | M | 82 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 14 years |
| Paul Wagner | M | 53 | - | |
| Rodney Lappe | M | 69 | 7 years | |
| Lori Kunkel | M | 66 | 5 years | |
| Shalini Sharp | F | 49 |
Panacea Acquisition Corp.
 Panacea Acquisition Corp. Financial ConglomeratesFinance Panacea Acquisition Corp. is a blank check company with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in April 2020 and is headquartered in San Francisco, CA. | 4 years |
| Daniel Vitt | M | 55 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | - |
| Marcus F. Boehm | M | 64 | 6 years | |
| Michael V. Swanson | M | 69 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 6 years |
| Vickie Reed | F | 62 | 9 years | |
| Bradford Goodwin | M | 69 |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | 4 years |
| David Hale | M | 75 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 10 years |
| Muneer Satter | M | 63 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 6 years |
| John Scarlett | M | 73 |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | 6 years |
| Graham Cooper | M | 54 | 2 years | |
| Cecil B. Pickett | M | 78 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 3 years |
| Kurt von Emster | M | 56 |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA.
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 8 years |
| Thomas Wiggans | M | 72 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 4 years |
| Christine R. Larson | F | 71 | 3 years | |
| Michael Martino | M | 68 | - | |
| Alan J. Lewis | M | 78 | 1 years | |
| Heidi Henson | F | 58 | 4 years | |
| Mark Foletta | M | 63 | 4 years | |
| Matthew Onaitis | M | 53 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 7 years |
| David Hinkle | M | - | - | |
| Maya Martinez-Davis | F | 54 | 6 years | |
| Temre Johnson | M | - | 5 years | |
| Jessica Oien | F | 53 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | - |
| John Moriarty | M | 56 | - | |
| Lowell E. Sears | M | 73 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 6 years |
| J. Michael Millis | M | 65 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 12 years |
| Jean-Jacques Bienaimé | M | 70 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 5 years |
| Michael Grey | M | 71 | 7 years | |
| John Dunn | M | 72 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 5 years |
| Bruce Carter | M | 80 | 8 years | |
| Tran Nguyen | M | 50 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | 3 years |
| Henry Fuchs | M | 66 | 11 years | |
| Craig Johnson | M | 62 | 11 years | |
| Robert Hoffman | M | 58 | 6 years | |
| Wen Kai Xiang | M | - | - | |
| Reena Desai | F | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 99.00% |
| United Kingdom | 1 | 1.00% |
| Canada | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Faheem Hasnain
- Personal Network
